Category: Health
Impella Flops for Acute Coronary Syndrome Patients Not in Shock
Source link : https://newshealth.biz/health-news/impella-flops-for-acute-coronary-syndrome-patients-not-in-shock/ NEW ORLEANS — Microaxial flow pump circulatory support with the Impella device during percutaneous coronary intervention (PCI) didn’t help outcomes for complex patients not in cardiogenic shock, two randomized trials at the American College of Cardiology (ACC) annual meeting showed. In an elective and largely stable but high-risk population in the…
Lower Really Is Better for Secondary Prevention Cholesterol Targets
Source link : https://newshealth.biz/health-news/lower-really-is-better-for-secondary-prevention-cholesterol-targets/ NEW ORLEANS — The more intensive LDL cholesterol target guidelines recommended for secondary prevention in high-risk patients with atherosclerotic cardiovascular (CV) disease improved outcomes in a randomized trial from South Korea. Compared with the LDL cholesterol target of less than 70 mg/dL typical for lower risk and primary prevention patients, targeting…
‘Who Would Do Something So Stupid?’: What We Heard This Week
Source link : https://newshealth.biz/health-news/who-would-do-something-so-stupid-what-we-heard-this-week/ “Conceptually, you might think, ‘Who would do something so stupid?’” — Elliot Fishman, MD, of Johns Hopkins Medicine in Baltimore, discussing the malicious potential of deepfake X-rays. “Sadly, younger physicians are about to be re-educated about what these diseases look like.” — Paul Offit, MD, of the Children’s Hospital of Philadelphia,…
Resistant Dermatomyositis Improves Quickly, Significantly With Combination Drug
Source link : https://newshealth.biz/health-news/resistant-dermatomyositis-improves-quickly-significantly-with-combination-drug/ DENVER — Treatment-resistant dermatomyositis improved significantly with the investigational TYK2/JAK1 inhibitor brepocitinib, according to a randomized trial. The higher of two doses of brepocitinib improved the total dermatomyositis score by almost 50% at 1 year as compared with placebo. The novel therapy demonstrated superiority over placebo across all nine secondary endpoints,…
PCKS9s Seen Driving Down LDL-C in Diabetes
Source link : https://newshealth.biz/health-news/pcks9s-seen-driving-down-ldl-c-in-diabetes/ A subgroup analysis of the VASALIUS-CV trial showed evolocumab significantly cut LDL cholesterol and cardiovascular event risk in people with diabetes but no known atherosclerosis. Medscape Medical News Source link : https://www.medscape.com/viewarticle/pcks9s-seen-driving-down-ldl-c-diabetes-2026a10009jb?src=rss Author : Publish date : 2026-03-29 18:16:00 Copyright for syndicated content belongs to the linked Source. The post PCKS9s…
Upadacitinib Significantly Improves Vitiligo vs Placebo
Source link : https://newshealth.biz/health-news/upadacitinib-significantly-improves-vitiligo-vs-placebo/ The JAK1 inhibitor in development for treating nonsegmental vitiligo was superior to placebo on investigator ratings in two phase 3 trials. Medscape Medical News Source link : https://www.medscape.com/viewarticle/upadacitinib-results-significant-improvements-nonsegmental-2026a10009j2?src=rss Author : Publish date : 2026-03-29 17:23:00 Copyright for syndicated content belongs to the linked Source. The post Upadacitinib Significantly Improves Vitiligo vs…
Dermatomyositis: Targeted Drug Shows Promise vs Placebo
Source link : https://newshealth.biz/health-news/dermatomyositis-targeted-drug-shows-promise-vs-placebo/ At 52 weeks, the 30-mg daily oral dose of brepocitinib outperformed the 15-mg dose in a study of patients with dermatomyositis resistant to previous treatments. Medscape Medical News Source link : https://www.medscape.com/viewarticle/dermatomyositis-targeted-drug-shows-promise-vs-placebo-2026a10009iz?src=rss Author : Publish date : 2026-03-29 16:39:00 Copyright for syndicated content belongs to the linked Source. The post Dermatomyositis:…
My Patients Are Asking for Leucovorin. Here’s What I Tell Them.
Source link : https://newshealth.biz/health-news/my-patients-are-asking-for-leucovorin-heres-what-i-tell-them/ When the White House announced it was exploring leucovorin as a treatment for autism, the calls from families started pouring in: “Can you prescribe leucovorin for my child?” We experience versions of this frequently: an unproven treatment gains momentum on social media, and we as physicians must become informed enough to…
Active Surveillance for DCIS Moves Closer to Standard Option but ‘Not Quite There’
Source link : https://newshealth.biz/health-news/active-surveillance-for-dcis-moves-closer-to-standard-option-but-not-quite-there/ Women who opted for active surveillance (AS) for ductal carcinoma in situ (DCIS) had ipsilateral invasive breast cancer survival (iiBCS) similar to patients who had immediate surgery, a randomized trial showed. After a total follow-up of about 4 years, iiBCS favored AS at 24 months (94.3% vs 90.6%) and met statistical…
Complement Inhibitor Slowed Kidney Decline in IgA Nephropathy
Source link : https://newshealth.biz/health-news/complement-inhibitor-slowed-kidney-decline-in-iga-nephropathy/ Iptacopan significantly slowed kidney function decline over 24 months compared with placebo in adults with IgA nephropathy. The complement inhibitor was granted accelerated approved in 2024; continued approval was contingent on demonstrating slowed kidney decline. Fewer participants in the iptacopan group reached the composite kidney-failure endpoint. Iptacopan (Fabhalta) slowed kidney function…
HI-PEITHO Kicks Off ‘Golden Era’ in Pulmonary Embolism
Source link : https://newshealth.biz/health-news/hi-peitho-kicks-off-golden-era-in-pulmonary-embolism/ NEW ORLEANS — A major advance for the treatment of intermediate-risk pulmonary embolism (PE) arrived with HI-PEITHO’s landmark report on ultrasound-facilitated, catheter-directed thrombolysis (CDT). In this hard-to-treat group of acute PE patients, the composite endpoint of PE-related death, cardiorespiratory decompensation or collapse, or symptomatic recurrence of PE within 7 days significantly…
PCSK9 Drug Prevents First Heart Events in Diabetes Patients Without Atherosclerosis
Source link : https://newshealth.biz/health-news/pcsk9-drug-prevents-first-heart-events-in-diabetes-patients-without-atherosclerosis/ NEW ORLEANS — Evolocumab (Repatha) reduced risk of a first major cardiovascular (CV) event in patients with diabetes but no known atherosclerosis in a substudy of the VESALIUS-CV trial. The PCSK9 inhibitor cut relative risk by 31% compared with placebo whether looking at the composite of death from coronary heart disease,…
Quiz Time: Can Radiologists Spot AI Deepfakes?
Source link : https://newshealth.biz/health-news/quiz-time-can-radiologists-spot-ai-deepfakes/ The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted daily, but keeping up can be a challenge. As an aid for our readers, and for a little amusement, here is a 10-question quiz based on…
Watchman LAA Occluder Bounces Back as Alternative to OAC in CHAMPION-AF
Source link : https://newshealth.biz/health-news/watchman-laa-occluder-bounces-back-as-alternative-to-oac-in-champion-af/ NEW ORLEANS — It may be reasonable for people with atrial fibrillation (Afib) to undergo percutaneous left atrial appendage (LAA) closure even if long-term anticoagulation is an alternative, according to the large CHAMPION-AF trial presented here. Three years after LAA closure with the Watchman FLX device, statistical criteria were met for…
Fibrinolytic Beats Current Standard for Intermediate-Risk PE
Source link : https://newshealth.biz/health-news/fibrinolytic-beats-current-standard-for-intermediate-risk-pe/ For intermediate-risk pulmonary embolism, a low-dose fibrinolysis strategy reduced PE-related events by half with no significant increase in bleeding vs standard therapy. Medscape Medical News Source link : https://www.medscape.com/viewarticle/fibrinolysis-treatment-validated-large-trial-acute-2026a10009im?src=rss Author : Publish date : 2026-03-28 21:20:00 Copyright for syndicated content belongs to the linked Source. The post Fibrinolytic Beats Current Standard…
LAAC an Alternative for NOAC in Lower-Risk AF Patients
Source link : https://newshealth.biz/health-news/laac-an-alternative-for-noac-in-lower-risk-af-patients/ CHAMPION-AF finds left atrial appendage closure and anticoagulation therapy for atrial fibrillation about equal but raises doubts about whether the former is a true alternative. Medscape Medical News Source link : https://www.medscape.com/viewarticle/champion-af-trial-finds-laac-alternative-noac-lower-risk-2026a10009ij?src=rss Author : Publish date : 2026-03-28 19:51:00 Copyright for syndicated content belongs to the linked Source. The post LAAC…
Kim Kardashian’s New Energy Drink Contains Paraxanthine: Is It Safe?
Source link : https://newshealth.biz/health-news/kim-kardashians-new-energy-drink-contains-paraxanthine-is-it-safe/ Share on PinterestKim Kardashian has released a new energy drink with paraxanthine instead of caffeine. Image credit: Axelle/Bauer-Griffin/Getty Images Kim Kardashian has launched a new energy drink called Update. Instead of caffeine, the drink contains paraxanthine. Paraxanthine is a compound naturally produced by the body when it breaks down caffeine. Kim…
Cooking and Dementia Risk; High-Dose vs Standard-Dose Flu Shot
Source link : https://newshealth.biz/health-news/cooking-and-dementia-risk-high-dose-vs-standard-dose-flu-shot/ TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of Texas Tech Health El Paso, look at the top medical stories of the week. This week’s topics include cooking and dementia risk, replacing…
We Have a Substance Use Prevention Problem
Source link : https://newshealth.biz/health-news/we-have-a-substance-use-prevention-problem/ Every week in the pediatric emergency department, I watch the consequences of adolescent substance use arrive through our doors. Overdoses. Acute intoxication. Psychiatric crises triggered by substances that started as experimentation years earlier. And almost every time, somewhere in the history, there is a moment when prevention could have worked —…
Roflumilast Promising for AD in Children Down to Age 3 Mos
Source link : https://newshealth.biz/health-news/roflumilast-promising-for-ad-in-children-down-to-age-3-mos/ Global assessment and itch/scratch scores highlight the effectiveness of topical roflumilast for treating atopic dermatitis in children 3 months to 2 years old, in a phase 2 study. Medscape Medical News Source link : https://www.medscape.com/viewarticle/roflumilast-shows-promise-treating-atopic-dermatitis-2026a10009ia?src=rss Author : Publish date : 2026-03-28 16:34:00 Copyright for syndicated content belongs to the linked Source.…
Pupil art sessions ‘bring joy’ to hospice
Source link : https://newshealth.biz/health-news/pupil-art-sessions-bring-joy-to-hospice/ The Hospice in the Weald in Pembury runs the sessions for people with life-limiting conditions. Source link : https://www.bbc.com/news/articles/c4gx92jedw2o?at_medium=RSS&at_campaign=rss Author : Publish date : 2026-03-28 16:06:00 Copyright for syndicated content belongs to the linked Source. The post Pupil art sessions ‘bring joy’ to hospice first appeared on News Health. —- Author…
Ceragenin-Coated Endotracheal Tubes Fail to Reduce Ventilator-Associated Pneumonia
Source link : https://newshealth.biz/health-news/ceragenin-coated-endotracheal-tubes-fail-to-reduce-ventilator-associated-pneumonia/ CHICAGO — Using endotracheal tubes (ETTs) coated with ceragenins did not reduce the incidence of ventilator-associated pneumonia (VAP) compared to standard subglottic suction ETTs, but mortality was lower with the ceragenin-coated ETTs, according to the CEASE VAP study. In the prospective, pragmatic crossover trial, VAP occurred in 19% of patients receiving…
Study Warns on Bad Advice, Other Dangers of Sycophantic Chatbots
Source link : https://newshealth.biz/health-news/study-warns-on-bad-advice-other-dangers-of-sycophantic-chatbots/ Artificial intelligence (AI) chatbots are so prone to flattering and validating their human users that they are giving bad advice that can damage relationships and reinforce harmful behaviors, according to a new study that explores the dangers of AI telling people what they want to hear. The study, published in Science,…
Insulin Resistance Detected Early May Guide HS Therapy
Source link : https://newshealth.biz/health-news/insulin-resistance-detected-early-may-guide-hs-therapy/ Screening for insulin resistance early after the diagnosis of hidradenitis suppurativa shows promise for guiding therapies to improve the disease course. Medscape Medical News Source link : https://www.medscape.com/viewarticle/insulin-resistance-detected-early-may-guide-hidradenitis-2026a10009i5?src=rss Author : Publish date : 2026-03-28 13:33:00 Copyright for syndicated content belongs to the linked Source. The post Insulin Resistance Detected Early May…
COVID-19 variant BA.3.2 is spreading briefly throughout US – a health care provider explains what you want to understand
Source link : https://health365.info/covid-19-variant-ba-3-2-is-spreading-briefly-throughout-us-a-health-care-provider-explains-what-you-want-to-understand/ A variant of COVID-19 referred to as BA.3.2, which has circulated beneath the radar since past due 2024, is now spreading briefly throughout the USA. As a pulmonary and significant care physician, I see many sufferers who’re at top possibility for serious COVID-19 because of persistent lung illness, in addition to…